Matthew obtained a first class honours degree in Genetics from The University of Sheffield before completing a PhD in Molecular Biology at the same institution. His doctoral thesis was focused on post-transcriptional gene regulation in humans, with a particular emphasis on the processes surrounding nuclear export of messenger RNA (mRNA).
Following completion of his PhD, Matthew worked for five years as a post-doctoral research fellow, initially continuing his work on the fundamental mechanisms of mRNA processing and export before moving to investigate these events in the context of the neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS). Matthew has authored several peer-reviewed papers and reviews based on work carried out during his research career and has presented data at both national and international conferences.
Matthew joined Potter Clarkson in 2014 and works in the Biotechnology and Pharmaceuticals team.